Update shared on04 Sep 2025
Capgemini’s valuation outlook remains stable, with consensus revenue growth and net profit margin both unchanged, resulting in an unchanged analyst price target of €175.93.
What's in the News
- Capgemini, Google Cloud, and Imperial War Museums announced a landmark AI-powered project transcribing and translating over 20,000 hours of oral histories, significantly improving accessibility and research capabilities through advanced generative AI.
- Capgemini partnered with EDETEK to accelerate digital transformation in life sciences, leveraging AI to optimize clinical development, improve efficiency, and reduce time-to-market for new therapies.
- Capgemini's Board scheduled a meeting to consider interim consolidated financial statements for the half-year ended June 30, 2025.
Valuation Changes
Summary of Valuation Changes for Capgemini
- The Consensus Analyst Price Target remained effectively unchanged, at €175.93.
- The Consensus Revenue Growth forecasts for Capgemini remained effectively unchanged, at 3.6% per annum.
- The Net Profit Margin for Capgemini remained effectively unchanged, at 8.23%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.